Estimation of FMO3 Ontogeny by Mechanistic Population Pharmacokinetic Modelling of Risdiplam and Its Impact on Drug–Drug Interactions in Children Article Swipe
Yumi Cleary
,
Heidemarie Kletzl
,
Paul Grimsey
,
Katja Heinig
,
Kayode Ogungbenro
,
Hanna Baumann
,
Nicolas Frey
,
Leon Aarons
,
Aleksandra Galetin
,
Michael Gertz
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1007/s40262-023-01241-7
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1007/s40262-023-01241-7
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1007/s40262-023-01241-7
- https://link.springer.com/content/pdf/10.1007/s40262-023-01241-7.pdf
- OA Status
- hybrid
- Cited By
- 12
- References
- 35
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4375855737
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4375855737Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1007/s40262-023-01241-7Digital Object Identifier
- Title
-
Estimation of FMO3 Ontogeny by Mechanistic Population Pharmacokinetic Modelling of Risdiplam and Its Impact on Drug–Drug Interactions in ChildrenWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-05-06Full publication date if available
- Authors
-
Yumi Cleary, Heidemarie Kletzl, Paul Grimsey, Katja Heinig, Kayode Ogungbenro, Hanna Baumann, Nicolas Frey, Leon Aarons, Aleksandra Galetin, Michael GertzList of authors in order
- Landing page
-
https://doi.org/10.1007/s40262-023-01241-7Publisher landing page
- PDF URL
-
https://link.springer.com/content/pdf/10.1007/s40262-023-01241-7.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://link.springer.com/content/pdf/10.1007/s40262-023-01241-7.pdfDirect OA link when available
- Concepts
-
Drug, Pharmacotherapy, Pharmacology, Pharmacokinetics, Population, Medicine, Estimation, Biology, Internal medicine, Management, Economics, Environmental healthTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
12Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 7, 2024: 5Per-year citation counts (last 5 years)
- References (count)
-
35Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4375855737 |
|---|---|
| doi | https://doi.org/10.1007/s40262-023-01241-7 |
| ids.doi | https://doi.org/10.1007/s40262-023-01241-7 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/37148485 |
| ids.openalex | https://openalex.org/W4375855737 |
| fwci | 21.19630385 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000328 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Adult |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D007223 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Infant |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D006801 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Humans |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D002648 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Child |
| mesh[4].qualifier_ui | Q000378 |
| mesh[4].descriptor_ui | D051544 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | metabolism |
| mesh[4].descriptor_name | Cytochrome P-450 CYP3A |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D011446 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Prospective Studies |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D008954 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Models, Biological |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D004347 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Drug Interactions |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D000328 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Adult |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D007223 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Infant |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D006801 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Humans |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D002648 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Child |
| mesh[12].qualifier_ui | Q000378 |
| mesh[12].descriptor_ui | D051544 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | metabolism |
| mesh[12].descriptor_name | Cytochrome P-450 CYP3A |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D011446 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Prospective Studies |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D008954 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Models, Biological |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D004347 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Drug Interactions |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D000328 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Adult |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D007223 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Infant |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D006801 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Humans |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D002648 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Child |
| mesh[20].qualifier_ui | Q000378 |
| mesh[20].descriptor_ui | D051544 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | metabolism |
| mesh[20].descriptor_name | Cytochrome P-450 CYP3A |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D011446 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Prospective Studies |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D008954 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Models, Biological |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D004347 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Drug Interactions |
| type | article |
| title | Estimation of FMO3 Ontogeny by Mechanistic Population Pharmacokinetic Modelling of Risdiplam and Its Impact on Drug–Drug Interactions in Children |
| biblio.issue | 6 |
| biblio.volume | 62 |
| biblio.last_page | 904 |
| biblio.first_page | 891 |
| grants[0].funder | https://openalex.org/F4320309432 |
| grants[0].award_id | |
| grants[0].funder_display_name | F. Hoffmann-La Roche |
| topics[0].id | https://openalex.org/T12547 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9973000288009644 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2735 |
| topics[0].subfield.display_name | Pediatrics, Perinatology and Child Health |
| topics[0].display_name | Pharmaceutical studies and practices |
| topics[1].id | https://openalex.org/T12191 |
| topics[1].field.id | https://openalex.org/fields/16 |
| topics[1].field.display_name | Chemistry |
| topics[1].score | 0.9891999959945679 |
| topics[1].domain.id | https://openalex.org/domains/3 |
| topics[1].domain.display_name | Physical Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1605 |
| topics[1].subfield.display_name | Organic Chemistry |
| topics[1].display_name | Chemical Reaction Mechanisms |
| topics[2].id | https://openalex.org/T11036 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.987500011920929 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2736 |
| topics[2].subfield.display_name | Pharmacology |
| topics[2].display_name | Antibiotics Pharmacokinetics and Efficacy |
| funders[0].id | https://openalex.org/F4320309432 |
| funders[0].ror | https://ror.org/00by1q217 |
| funders[0].display_name | F. Hoffmann-La Roche |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2780035454 |
| concepts[0].level | 2 |
| concepts[0].score | 0.6917816996574402 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q8386 |
| concepts[0].display_name | Drug |
| concepts[1].id | https://openalex.org/C500440147 |
| concepts[1].level | 2 |
| concepts[1].score | 0.5192829966545105 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q701216 |
| concepts[1].display_name | Pharmacotherapy |
| concepts[2].id | https://openalex.org/C98274493 |
| concepts[2].level | 1 |
| concepts[2].score | 0.5082516074180603 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[2].display_name | Pharmacology |
| concepts[3].id | https://openalex.org/C112705442 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5044187307357788 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q323936 |
| concepts[3].display_name | Pharmacokinetics |
| concepts[4].id | https://openalex.org/C2908647359 |
| concepts[4].level | 2 |
| concepts[4].score | 0.4981527328491211 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[4].display_name | Population |
| concepts[5].id | https://openalex.org/C71924100 |
| concepts[5].level | 0 |
| concepts[5].score | 0.47171729803085327 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[5].display_name | Medicine |
| concepts[6].id | https://openalex.org/C96250715 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4234768748283386 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q965330 |
| concepts[6].display_name | Estimation |
| concepts[7].id | https://openalex.org/C86803240 |
| concepts[7].level | 0 |
| concepts[7].score | 0.3322884142398834 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[7].display_name | Biology |
| concepts[8].id | https://openalex.org/C126322002 |
| concepts[8].level | 1 |
| concepts[8].score | 0.19737404584884644 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[8].display_name | Internal medicine |
| concepts[9].id | https://openalex.org/C187736073 |
| concepts[9].level | 1 |
| concepts[9].score | 0.0 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q2920921 |
| concepts[9].display_name | Management |
| concepts[10].id | https://openalex.org/C162324750 |
| concepts[10].level | 0 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q8134 |
| concepts[10].display_name | Economics |
| concepts[11].id | https://openalex.org/C99454951 |
| concepts[11].level | 1 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[11].display_name | Environmental health |
| keywords[0].id | https://openalex.org/keywords/drug |
| keywords[0].score | 0.6917816996574402 |
| keywords[0].display_name | Drug |
| keywords[1].id | https://openalex.org/keywords/pharmacotherapy |
| keywords[1].score | 0.5192829966545105 |
| keywords[1].display_name | Pharmacotherapy |
| keywords[2].id | https://openalex.org/keywords/pharmacology |
| keywords[2].score | 0.5082516074180603 |
| keywords[2].display_name | Pharmacology |
| keywords[3].id | https://openalex.org/keywords/pharmacokinetics |
| keywords[3].score | 0.5044187307357788 |
| keywords[3].display_name | Pharmacokinetics |
| keywords[4].id | https://openalex.org/keywords/population |
| keywords[4].score | 0.4981527328491211 |
| keywords[4].display_name | Population |
| keywords[5].id | https://openalex.org/keywords/medicine |
| keywords[5].score | 0.47171729803085327 |
| keywords[5].display_name | Medicine |
| keywords[6].id | https://openalex.org/keywords/estimation |
| keywords[6].score | 0.4234768748283386 |
| keywords[6].display_name | Estimation |
| keywords[7].id | https://openalex.org/keywords/biology |
| keywords[7].score | 0.3322884142398834 |
| keywords[7].display_name | Biology |
| keywords[8].id | https://openalex.org/keywords/internal-medicine |
| keywords[8].score | 0.19737404584884644 |
| keywords[8].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.1007/s40262-023-01241-7 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S69290020 |
| locations[0].source.issn | 0312-5963, 1179-1926 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0312-5963 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Clinical Pharmacokinetics |
| locations[0].source.host_organization | https://openalex.org/P4310320330 |
| locations[0].source.host_organization_name | Adis, Springer Healthcare |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320330 |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | https://link.springer.com/content/pdf/10.1007/s40262-023-01241-7.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Clinical Pharmacokinetics |
| locations[0].landing_page_url | https://doi.org/10.1007/s40262-023-01241-7 |
| locations[1].id | pmid:37148485 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Clinical pharmacokinetics |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/37148485 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10256639 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by-nc |
| locations[2].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10256639/pdf/40262_2023_Article_1241.pdf |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Clin Pharmacokinet |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10256639 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5014752554 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-9703-7269 |
| authorships[0].author.display_name | Yumi Cleary |
| authorships[0].countries | CH, GB |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I28407311 |
| authorships[0].affiliations[0].raw_affiliation_string | Centre for Applied Pharmacokinetic Research, University of Manchester, Manchester, UK. [email protected]. |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I118019719 |
| authorships[0].affiliations[1].raw_affiliation_string | Roche Pharma Research and Early Development, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070, Basel, Switzerland. [email protected]. |
| authorships[0].institutions[0].id | https://openalex.org/I118019719 |
| authorships[0].institutions[0].ror | https://ror.org/00by1q217 |
| authorships[0].institutions[0].type | company |
| authorships[0].institutions[0].lineage | https://openalex.org/I118019719 |
| authorships[0].institutions[0].country_code | CH |
| authorships[0].institutions[0].display_name | Roche (Switzerland) |
| authorships[0].institutions[1].id | https://openalex.org/I28407311 |
| authorships[0].institutions[1].ror | https://ror.org/027m9bs27 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I28407311 |
| authorships[0].institutions[1].country_code | GB |
| authorships[0].institutions[1].display_name | University of Manchester |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Yumi Cleary |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Centre for Applied Pharmacokinetic Research, University of Manchester, Manchester, UK. [email protected]., Roche Pharma Research and Early Development, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070, Basel, Switzerland. [email protected]. |
| authorships[1].author.id | https://openalex.org/A5002367971 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-8129-2196 |
| authorships[1].author.display_name | Heidemarie Kletzl |
| authorships[1].countries | CH |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I118019719 |
| authorships[1].affiliations[0].raw_affiliation_string | Roche Pharma Research and Early Development, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070, Basel, Switzerland. |
| authorships[1].institutions[0].id | https://openalex.org/I118019719 |
| authorships[1].institutions[0].ror | https://ror.org/00by1q217 |
| authorships[1].institutions[0].type | company |
| authorships[1].institutions[0].lineage | https://openalex.org/I118019719 |
| authorships[1].institutions[0].country_code | CH |
| authorships[1].institutions[0].display_name | Roche (Switzerland) |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Heidemarie Kletzl |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Roche Pharma Research and Early Development, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070, Basel, Switzerland. |
| authorships[2].author.id | https://openalex.org/A5065270714 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Paul Grimsey |
| authorships[2].countries | GB |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210113058 |
| authorships[2].affiliations[0].raw_affiliation_string | Roche Pharma Research and Early Development, Roche Innovation Center, Welwyn, UK. |
| authorships[2].institutions[0].id | https://openalex.org/I4210113058 |
| authorships[2].institutions[0].ror | https://ror.org/024tgbv41 |
| authorships[2].institutions[0].type | company |
| authorships[2].institutions[0].lineage | https://openalex.org/I118019719, https://openalex.org/I4210113058 |
| authorships[2].institutions[0].country_code | GB |
| authorships[2].institutions[0].display_name | Roche (United Kingdom) |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Paul Grimsey |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Roche Pharma Research and Early Development, Roche Innovation Center, Welwyn, UK. |
| authorships[3].author.id | https://openalex.org/A5004205987 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Katja Heinig |
| authorships[3].countries | CH |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I118019719 |
| authorships[3].affiliations[0].raw_affiliation_string | Roche Pharma Research and Early Development, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070, Basel, Switzerland. |
| authorships[3].institutions[0].id | https://openalex.org/I118019719 |
| authorships[3].institutions[0].ror | https://ror.org/00by1q217 |
| authorships[3].institutions[0].type | company |
| authorships[3].institutions[0].lineage | https://openalex.org/I118019719 |
| authorships[3].institutions[0].country_code | CH |
| authorships[3].institutions[0].display_name | Roche (Switzerland) |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Katja Heinig |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Roche Pharma Research and Early Development, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070, Basel, Switzerland. |
| authorships[4].author.id | https://openalex.org/A5039851568 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-2446-6895 |
| authorships[4].author.display_name | Kayode Ogungbenro |
| authorships[4].countries | GB |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I28407311 |
| authorships[4].affiliations[0].raw_affiliation_string | Centre for Applied Pharmacokinetic Research, University of Manchester, Manchester, UK. |
| authorships[4].institutions[0].id | https://openalex.org/I28407311 |
| authorships[4].institutions[0].ror | https://ror.org/027m9bs27 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I28407311 |
| authorships[4].institutions[0].country_code | GB |
| authorships[4].institutions[0].display_name | University of Manchester |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Kayode Ogungbenro |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Centre for Applied Pharmacokinetic Research, University of Manchester, Manchester, UK. |
| authorships[5].author.id | https://openalex.org/A5110977527 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Hanna Baumann |
| authorships[5].countries | CH |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I118019719 |
| authorships[5].affiliations[0].raw_affiliation_string | Roche Pharma Research and Early Development, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070, Basel, Switzerland. |
| authorships[5].institutions[0].id | https://openalex.org/I118019719 |
| authorships[5].institutions[0].ror | https://ror.org/00by1q217 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I118019719 |
| authorships[5].institutions[0].country_code | CH |
| authorships[5].institutions[0].display_name | Roche (Switzerland) |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Hanna Elisabeth Silber Baumann |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Roche Pharma Research and Early Development, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070, Basel, Switzerland. |
| authorships[6].author.id | https://openalex.org/A5103842925 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Nicolas Frey |
| authorships[6].countries | CH |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I118019719 |
| authorships[6].affiliations[0].raw_affiliation_string | Roche Pharma Research and Early Development, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070, Basel, Switzerland. |
| authorships[6].institutions[0].id | https://openalex.org/I118019719 |
| authorships[6].institutions[0].ror | https://ror.org/00by1q217 |
| authorships[6].institutions[0].type | company |
| authorships[6].institutions[0].lineage | https://openalex.org/I118019719 |
| authorships[6].institutions[0].country_code | CH |
| authorships[6].institutions[0].display_name | Roche (Switzerland) |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Nicolas Frey |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Roche Pharma Research and Early Development, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070, Basel, Switzerland. |
| authorships[7].author.id | https://openalex.org/A5004605882 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-2704-6570 |
| authorships[7].author.display_name | Leon Aarons |
| authorships[7].countries | GB |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I28407311 |
| authorships[7].affiliations[0].raw_affiliation_string | Centre for Applied Pharmacokinetic Research, University of Manchester, Manchester, UK. |
| authorships[7].institutions[0].id | https://openalex.org/I28407311 |
| authorships[7].institutions[0].ror | https://ror.org/027m9bs27 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I28407311 |
| authorships[7].institutions[0].country_code | GB |
| authorships[7].institutions[0].display_name | University of Manchester |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Leon Aarons |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Centre for Applied Pharmacokinetic Research, University of Manchester, Manchester, UK. |
| authorships[8].author.id | https://openalex.org/A5059236152 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-3933-5217 |
| authorships[8].author.display_name | Aleksandra Galetin |
| authorships[8].countries | GB |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I28407311 |
| authorships[8].affiliations[0].raw_affiliation_string | Centre for Applied Pharmacokinetic Research, University of Manchester, Manchester, UK. |
| authorships[8].institutions[0].id | https://openalex.org/I28407311 |
| authorships[8].institutions[0].ror | https://ror.org/027m9bs27 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I28407311 |
| authorships[8].institutions[0].country_code | GB |
| authorships[8].institutions[0].display_name | University of Manchester |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Aleksandra Galetin |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Centre for Applied Pharmacokinetic Research, University of Manchester, Manchester, UK. |
| authorships[9].author.id | https://openalex.org/A5061021795 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-4530-6110 |
| authorships[9].author.display_name | Michael Gertz |
| authorships[9].countries | CH |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I118019719 |
| authorships[9].affiliations[0].raw_affiliation_string | Roche Pharma Research and Early Development, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070, Basel, Switzerland. [email protected]. |
| authorships[9].institutions[0].id | https://openalex.org/I118019719 |
| authorships[9].institutions[0].ror | https://ror.org/00by1q217 |
| authorships[9].institutions[0].type | company |
| authorships[9].institutions[0].lineage | https://openalex.org/I118019719 |
| authorships[9].institutions[0].country_code | CH |
| authorships[9].institutions[0].display_name | Roche (Switzerland) |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | Michael Gertz |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Roche Pharma Research and Early Development, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070, Basel, Switzerland. [email protected]. |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://link.springer.com/content/pdf/10.1007/s40262-023-01241-7.pdf |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Estimation of FMO3 Ontogeny by Mechanistic Population Pharmacokinetic Modelling of Risdiplam and Its Impact on Drug–Drug Interactions in Children |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12547 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9973000288009644 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2735 |
| primary_topic.subfield.display_name | Pediatrics, Perinatology and Child Health |
| primary_topic.display_name | Pharmaceutical studies and practices |
| related_works | https://openalex.org/W2352350815, https://openalex.org/W2991030316, https://openalex.org/W2908757458, https://openalex.org/W2887865523, https://openalex.org/W2112528869, https://openalex.org/W4364376666, https://openalex.org/W2141289501, https://openalex.org/W2960553615, https://openalex.org/W3043458966, https://openalex.org/W2162491061 |
| cited_by_count | 12 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 7 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 5 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1007/s40262-023-01241-7 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S69290020 |
| best_oa_location.source.issn | 0312-5963, 1179-1926 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0312-5963 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Clinical Pharmacokinetics |
| best_oa_location.source.host_organization | https://openalex.org/P4310320330 |
| best_oa_location.source.host_organization_name | Adis, Springer Healthcare |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320330 |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | https://link.springer.com/content/pdf/10.1007/s40262-023-01241-7.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Clinical Pharmacokinetics |
| best_oa_location.landing_page_url | https://doi.org/10.1007/s40262-023-01241-7 |
| primary_location.id | doi:10.1007/s40262-023-01241-7 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S69290020 |
| primary_location.source.issn | 0312-5963, 1179-1926 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0312-5963 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Clinical Pharmacokinetics |
| primary_location.source.host_organization | https://openalex.org/P4310320330 |
| primary_location.source.host_organization_name | Adis, Springer Healthcare |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320330 |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | https://link.springer.com/content/pdf/10.1007/s40262-023-01241-7.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Clinical Pharmacokinetics |
| primary_location.landing_page_url | https://doi.org/10.1007/s40262-023-01241-7 |
| publication_date | 2023-05-06 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W1980477780, https://openalex.org/W2143197369, https://openalex.org/W2883929619, https://openalex.org/W2405092992, https://openalex.org/W3203417747, https://openalex.org/W2896569528, https://openalex.org/W2902046607, https://openalex.org/W2068390361, https://openalex.org/W1594693399, https://openalex.org/W2746768441, https://openalex.org/W2155201524, https://openalex.org/W2319311314, https://openalex.org/W2111899360, https://openalex.org/W2021604269, https://openalex.org/W3190812721, https://openalex.org/W2117800297, https://openalex.org/W1994057917, https://openalex.org/W1909569905, https://openalex.org/W1978867369, https://openalex.org/W1968101595, https://openalex.org/W1970036717, https://openalex.org/W3108512086, https://openalex.org/W1605785874, https://openalex.org/W2114123573, https://openalex.org/W2161213051, https://openalex.org/W3205535888, https://openalex.org/W2120416054, https://openalex.org/W2887001877, https://openalex.org/W4229672954, https://openalex.org/W2076085146, https://openalex.org/W1984452104, https://openalex.org/W2301312115, https://openalex.org/W2020697761, https://openalex.org/W2123282873, https://openalex.org/W188932586 |
| referenced_works_count | 35 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 98 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 10 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8199999928474426 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.97429898 |
| citation_normalized_percentile.is_in_top_1_percent | True |
| citation_normalized_percentile.is_in_top_10_percent | True |